Milestone Pharmaceuticals : Corporate Presentation -March 28, 2024 at 08:38 am EDT

Company Overview


March 28, 2024


Forward Looking Statement


The Presentation contains forward-looking statements within...

Related Keywords

United States ,American , ,Milestone Pharmaceuticals ,American Heart Association ,Emergency Department ,Company Overview ,Exchange Commission ,Milestone Pharmaceuticals Data On File ,Blueprint Research Group ,Private Securities Litigation Reform Act ,Quarterly Report ,Give Patients Control ,Common Heart ,Etripamil Nasal Spray ,Successful Phase ,Positive Phase ,Science Presentation ,Paroxysmal Supraventricular Tachycardia ,Atrial Fibrillation ,Rapid Ventricular Rate ,New Drug Application ,Markedly Symptomatic Attacks That Disrupt Patient ,Rapid Ventricular ,Acute Attacks ,Nasal Spray ,Treat Episodes ,Hospital Admissions ,Addressable Market ,Heart Association ,Triangle Insights ,Interventional Cardiologists ,Pipeline Advancement ,New Drug ,File Notice ,Drug Application ,Rapid Conversion ,Sinus Rhythm ,Repeat Episodes ,Milestone Pharmaceuticals Data ,Markets ,